These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20834098)

  • 1. Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant.
    Brunelle MN; Saboulard D; Massinet H; Lamant C; Soussan P; Brezillon N; Kremsdorf D
    Antivir Ther; 2010; 15(6):861-9. PubMed ID: 20834098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
    Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
    Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
    Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
    Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Morrey JD; Korba BE; Sidwell RW
    Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine inhibition of the hepatitis B virus core promoter.
    Romero R; Lavine JE
    Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifs.
    Li N; Fan XG; Chen ZH; Zhu C; Liu HB; Huang Y
    Immunol Lett; 2006 Jan; 102(1):60-6. PubMed ID: 16105691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication].
    Song JW; Zhang G; Lin JG; Tang WX; Lin JS
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of different PAP domains on hepatitis B virus replication].
    Guo CX; He YW; Peng C; Lei YC; Li WT
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):105-8. PubMed ID: 20196948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
    Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
    J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
    Wakui Y; Inoue J; Ueno Y; Fukushima K; Kondo Y; Kakazu E; Obara N; Kimura O; Shimosegawa T
    Biochem Biophys Res Commun; 2010 May; 396(2):508-14. PubMed ID: 20430009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
    Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
    J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
    Zoulim F
    Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein.
    Han J; Pan X; Gao Y; Weil L
    Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress.
    Togashi H; Ohno S; Matsuo T; Watanabe H; Saito T; Shinzawa H; Takahashi T
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):407-17. PubMed ID: 11589367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.